Tusk IC Raises $17.4M Series A Funding

Octave.energy

Power Your Business | Cutting Edge Energy Management and Storage Systems

Paleo

At Paleo, we are rewriting the story of meat. First, we hunted. Then, we bred. Now, we brew. We brew the crucial meat ingredient that makes plant-based products look, taste and act more like the real deal. By helping manufacturers in convincing consumers, we accelerate the #ProteinShift. Because we care. We care for the animals, for our next generations and for providing nutritious foods. We care for the planet and the legacy that we’ll pass on. That's why, to produce our animal heme proteins, we no longer use animals. Instead, we use yeast. At Paleo, we don’t need to breed, transport or slaughter livestock. We don’t use any antibiotics or hormones, and our product is free of GMOs. Our process of fermentation uses less land, energy and water. It emits far less greenhouse gases and contributes to ending the immense loss of biodiversity on earth. The result is groundbreaking alternative proteins that are bio-identical to those found in animal meat. Identical in taste, look and nutrition. They provide food manufacturers with the same taste, but they come with a different story. Join us on our path to rewrite the story of meat. http://paleo.bio

Amyl Therapeutics

Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, or by systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.